Drug Type Small molecule drug |
Synonyms GS 9256, GS-337152 |
Target |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors), NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC46H56ClF2N6O8PS |
InChIKeyRFGUWOCFYCYEDM-ZOMNBDOOSA-N |
CAS Registry1001094-46-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic hepatitis C genotype 1 | Phase 2 | BE | 01 Feb 2010 | |
Chronic hepatitis C genotype 1 | Phase 2 | FR | 01 Feb 2010 | |
Chronic hepatitis C genotype 1 | Phase 2 | DE | 01 Feb 2010 | |
Chronic hepatitis C genotype 1 | Phase 2 | GB | 01 Feb 2010 | |
Hepatitis C | Preclinical | US | 01 Feb 2012 |